Neoleukin Therapeutics, Inc.

NasdaqCM:NLTX Stock Report

Market Cap: US$32.8m

Neoleukin Therapeutics, Inc. Company Information

Neoleukin Therapeutics, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Neoleukin Therapeutics, Inc.
  • Ticker: NLTX
  • Exchange: NasdaqCM
  • Founded: 2003
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$32.799m
  • Shares Outstanding: 2.35m
  • Website: https://www.neoleukin.com

Number of Employees


Location

  • Neoleukin Therapeutics, Inc.
  • 188 East Blaine Street
  • Suite 450
  • Seattle
  • Washington
  • 98102
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NLTXNasdaqCM (Nasdaq Capital Market)YesUSA Common StockUSUSDMar 2014

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/12/20 05:11
End of Day Share Price 2023/12/18 00:00
Earnings2023/09/30
Annual Earnings2022/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.